Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 189.93

+0.5%

Jan 2 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hippieslayer who wrote (22928)	7/9/1998 9:19:00 AM
From: Henry Niman	of 32384

At a Nuclear Hormone conference in October (also in San Diego) LGND will talk about use of its various rexinoid to decode cross-talk and heterodimerization: Retinoids, the Next Generation: Gene and Dimer-Specific Rexinoids Deepak S. Lala, Ph.D., Research Scientist, Department of Retinoid Research, Ligand Pharmaceuticals Inc. RXR is considered a master receptor due to its ability to form heterodimers with other members of the nuclear receptor super-family. This talk will cover our recent work on the nuclear receptor RXR, using unique small molecule ligands to decipher novel functional properties of RXR dimers and their impact upon RXR signaling.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next